Polyacrylamide hydrogel (PAHG; Bulkamid , Contura International A/S, Søborg, Denmark) is a urethral bulking agent (UBA) commonly used in the treatment of stress urinary incontinence (SUI). However, long-term clinical data… Click to show full abstract
Polyacrylamide hydrogel (PAHG; Bulkamid , Contura International A/S, Søborg, Denmark) is a urethral bulking agent (UBA) commonly used in the treatment of stress urinary incontinence (SUI). However, long-term clinical data are limited. The aim of this study was to describe outcomes associated with PAHG injections in women with SUI. The primary outcome was treatment success. Secondary outcomes included incontinence impact, urinary distress, pain under local anaesthesia, willingness to refer PAHG treatment to a friend, and adverse events.
Journal Title: Bju International
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!